LENSAR, Inc. (LNSR) vs Myomo, Inc. (MYO)
- LENSAR, Inc. LNSR 5.80 −3.81%
- Myomo, Inc. MYO 1.20 −7.69%
LENSAR, Inc. and Myomo, Inc. are both Medical Devices companies. LENSAR, Inc. is the larger, with a market value of $74.1M against $51.5M — 1.4× the size. Myomo, Inc. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 2.0×. Myomo, Inc. grew revenue faster over the last twelve months: 6.14% against 3.26%. LENSAR, Inc. has the higher net margin (57.6% vs −33.5%) and the lower return on invested capital (−379.0% vs −167.9%). Across the 18 metrics below, LENSAR, Inc. leads on 12 and Myomo, Inc. on 6.
Valuation
Profitability
| Metric | LNSR | MYO | Medical Devices median |
|---|---|---|---|
| Gross margin | 48.34% | 68.35% | 56.01% |
| Operating margin | (13.48%) | (27.05%) | (15.03%) |
| Net margin | 57.57% | (33.53%) | (20.40%) |
| Free cash flow margin | (12.29%) | (21.01%) | (7.24%) |
| Return on equity | (851.75%) | (123.76%) | (15.32%) |
| Return on assets | 49.58% | (39.20%) | (19.72%) |
| Return on invested capital | (379.01%) | (167.90%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack